Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Type 2 Diabetes with Moderate Renal Impairment (LIRA-RENAL)
NCT01620489Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2012
- Primary completion
- Aug 2013
- Countries
- 6
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01620489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620489.